Literature DB >> 19811283

AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis.

Hans L A Nienhuis1, Johanna Westra, Andries J Smit, Pieter C Limburg, Cees G M Kallenberg, Marc Bijl.   

Abstract

Systemic autoimmune diseases are associated with inflammation, and oxidative stress favouring the formation of advanced glycation endproducts (AGE), able to modulate cellular functions by activation of receptor for advanced glycation endproducts (RAGE). As RAGE expression is increased in an inflammatory milieu, present in patients with systemic autoimmune diseases, these patients are especially prone for the deleterious effects of AGE. Interaction of AGE with RAGE leads to intracellular signalling, and subsequent expression of adhesion molecules, chemokines, pro-inflammatory cytokines and up-regulation of RAGE itself. The AGE-RAGE interaction might act as a pro-inflammatory loop in these patients, contributing to chronic low grade inflammation rendering these individuals susceptible for development of accelerated atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811283     DOI: 10.1080/08916930902831746

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  17 in total

Review 1.  The mechanism of protracted wound healing on oral mucosa in diabetes. Review.

Authors:  Yoshihiro Abiko; Denis Selimovic
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

2.  Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness.

Authors:  Hans L A Nienhuis; Karina de Leeuw; Johan Bijzet; Jasper J van Doormaal; Arie M van Roon; Andries J Smit; Reindert Graaff; Cees G M Kallenberg; Marc Bijl
Journal:  Arthritis Res Ther       Date:  2010-09-28       Impact factor: 5.156

Review 3.  Glycation & the RAGE axis: targeting signal transduction through DIAPH1.

Authors:  Alexander Shekhtman; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Expert Rev Proteomics       Date:  2016-12-22       Impact factor: 3.940

4.  Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.

Authors:  M Sorice; B Buttari; A Capozzi; E Profumo; F Facchiano; S Truglia; S Recalchi; C Alessandri; F Conti; R Misasi; G Valesini; R Riganò
Journal:  Clin Exp Immunol       Date:  2016-02-15       Impact factor: 4.330

Review 5.  The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease.

Authors:  Ravichandran Ramasamy; Alexander Shekhtman; Ann Marie Schmidt
Journal:  Expert Opin Ther Targets       Date:  2015-11-11       Impact factor: 6.902

Review 6.  The clearance of dead cells by efferocytosis.

Authors:  Emilio Boada-Romero; Jennifer Martinez; Bradlee L Heckmann; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2020-04-06       Impact factor: 94.444

Review 7.  Oxidative stress in the pathology and treatment of systemic lupus erythematosus.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2013-10-08       Impact factor: 20.543

8.  Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells.

Authors:  Gilbert J Cote; Wen Zhu; Anthony Thomas; Emil Martin; Ferid Murad; Iraida G Sharina
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

9.  Skin autofluorescence based decision tree in detection of impaired glucose tolerance and diabetes.

Authors:  Andries J Smit; Jitske M Smit; Gijs J Botterblom; Douwe J Mulder
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

Review 10.  Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.

Authors:  Nontaphat Leerach; Ai Harashima; Seiichi Munesue; Kumi Kimura; Yu Oshima; Hisanori Goto; Hiroshi Yamamoto; Haruhiro Higashida; Yasuhiko Yamamoto
Journal:  Glycoconj J       Date:  2020-10-27       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.